EichorEICHOR
Location: La Mesa Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near La Mesa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318Survey on Epidemiology of Hypoparathyroidism in France
Phase N/A · European Georges Pompidou Hospital · NCT02838927Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · University Hospital, Lille · NCT05572229Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Eli Lilly and Company · NCT07353931Dat'Aids Prevention
Phase N/A · DatAids · NCT03795376A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Pfizer · NCT06629779Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · Bayer · NCT04142437A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Children's Oncology Group · NCT04293562Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
Phase 2 · Assistance Publique - Hôpitaux de Paris · NCT04789850A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Crystalys Therapeutics · NCT07089888Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns
Phase 3 · Nantes University Hospital · NCT06968559Project: Every Child for Younger Patients With Cancer
Phase N/A · Children's Oncology Group · NCT02402244Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Pfizer · NCT07222800Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Children's Oncology Group · NCT05235165Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Alnylam Pharmaceuticals · NCT07181109A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · Purushotham & Akther Kotha MD, Inc · Eli Lilly and Company · NCT06864026A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · Crystalys Therapeutics · NCT07089875Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic A
NA · Hospices Civils de Lyon · NCT03290456A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · National Cancer Institute (NCI) · NCT04166409Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy
Phase N/A · Elsan · NCT04638088Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Phase 3 · MoonLake Immunotherapeutics AG · NCT06641089A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · National Cancer Institute (NCI) · NCT05675410Quality of Care in French HIV Infected Patients
Phase N/A · DatAids · NCT02898987A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · National Cancer Institute (NCI) · NCT04546399A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · AbbVie · NCT07136467
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.